Eyewire News

Retina Community Mourns the Loss of Ramin Tadayoni, MD, PhD

Prof. Ramin Tadayoni, MD, PhD, a giant in the global retina community, has passed away.

Read Story

DigitalOptometrics Surpasses 2 Million Remote Eye Exams

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

Alivi Health Unveils New Vision Program

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

View All News

Stocks

Sort by:

Change A-Z

AbbVie $169.62 1.03%

Adverum Biotechnologies $11.49 1.28%

Alcon $81.01 0.50%

Aldeyra Therapeutics $4.05 2.93%

Alimera Sciences $3.57 0.85%

Apellis Pharmaceuticals $48.48 1.76%

Astellas Pharma $9.53 0.32%

Bausch + Lomb $14.98 2.32%

Bausch Health Companies $8.52 0.83%

Bayer $7.36 3.88%

Biogen $193.93 -0.09%

Can-Fite Biopharma $1.98 0.00%

Clearside Biomedical $1.40 -0.71%

Cooper Companies $90.98 1.04%

Eyenovia $0.52 0.64%

EyePoint Pharmaceuticals $18.16 7.11%

Glaukos $99.32 0.37%

Harrow Health $10.65 0.47%

Hill-Rom $155.96 0.03%

Horizon Therapeutics $116.30 0.00%

InMed Pharmaceuticals $0.28 -3.50%

Iridex Corporation $2.92 1.74%

Johnson & Johnson $149.75 0.42%

Kala Pharmaceuticals $6.33 -3.95%

Kiora Pharmaceuticals $0.49 -1.08%

Lensar $3.26 0.31%

Lineage Cell Therapeutics $1.17 2.63%

MeiraGTx Holdings $4.96 -1.20%

Merck & Company $126.93 -0.01%

National Vision Holdings $18.87 2.33%

NovaBay Pharmaceuticals $0.07 -12.01%

Novartis AG Common Stock $97.50 2.50%

Ocugen $1.29 4.03%

Ocular Therapeutix $5.01 -1.28%

Oculis $11.90 -0.42%

Ocuphire Pharma $1.54 1.99%

Omeros Corp. $3.16 2.44%

Osmotica $1.11 -1.77%

Outlook Therapeutics $8.19 1.24%

Palatin Technologies $1.77 2.62%

Regeneron $904.60 0.49%

Regenxbio $15.89 1.57%

Roche $30.91 1.64%

Sight Sciences $5.64 5.03%

STAAR Surgical Company $47.19 1.36%

Takeda Pharmaceutical Company $13.36 -0.04%

Tarsus Pharmaceuticals $33.43 3.53%

Viatris $11.35 0.84%

View More Stocks

Cataract

The Metaverse in Ophthalmology?

A review of current and upcoming virtual reality simulators for microsurgical training.

Geoffrey Nguyen, MD, and Paul Kang, MD

Cataract and Refractive Surgery Today

The use of virtual reality (VR) for ophthalmologic surgical training is a captivating topic. Recent technological advances have propelled an unprecedented level of research in this area—especially timely during the COVID-19 pandemic. This public health emergency prompted ophthalmology residency programs to explore surgical training resources that allow residents to practice microsurgical skills without direct patient contact. The proliferation of VR headsets, haptic technology, and virtual education has enabled educational innovators to offer a reliable, high-fidelity alternative to traditional surgical training methods. These innovative simulators allow ophthalmology trainees to receive real-time feedback and visual guidance for cataract and vitreoretinal surgery from educators worldwide. Some devices have become foundational to the surgical curricula of many ophthalmology institutions, whereas others are just becoming commercially available. This brief overview highlights some remarkable surgical simulators and future plans for integrating VR into ophthalmology. EyeSi Surgical Simulator The EyeSi Surgical Simulator (Haag-Streit USA), the most established device of its kind, has been integrated into more than 650 ophthalmology residency programs worldwide. The unit comprises a virtual operating microscope for simulating stereoscopic images, handheld probes for simulating instruments when inserted into an artificial eye, and a programmable virtual environment for phaco cataract or vitreoretinal surgery. Tasks can be performed while an instructor monitors them on a viewing panel (Figure 1).

Chandelier Retroillumination in a Complex Cataract Extraction

Birkaran Sadhar, and Eric D. Rosenberg, DO, MScEng

Eyetube

Combining Vitreoretinal Surgery With EDOF IOL Implantation

The lens technology’s potential to reduce patients’ trips to the OR and loss of accommodation.

Peter Stalmans, MD, PhD

Cataract and Refractive Surgery Today

Artificial Intelligence Assisted Eye Care

Shail Vasavada, MD; Samaresh Srivastava, MD; Ashok Puri, MD; Vaishali Vasavada, MD; and Abhay Vasavada, MD

Eyetube

Dense Cataract in Pseudoexfoliation Syndrome

Marisa Schoen, MD

Eyetube

Effective Preoperative Assessment and Management of the Ocular Surface

Tips for optimizing the ocular surface and therefore surgical success.

Priya M. Mathews, MD, MPH

Cataract and Refractive Surgery Today

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Refractive

Combining Vitreoretinal Surgery With EDOF IOL Implantation

The lens technology’s potential to reduce patients’ trips to the OR and loss of accommodation.

Peter Stalmans, MD, PhD

Cataract and Refractive Surgery Today

Cataract surgery is often thought of as an age-related procedure. In numerous European countries, however, including Belgium, where I practice, many patients receiving a vitrectomy undergo concurrent cataract surgery if they are older than 50 years of age to minimize the number of surgical procedures they will require and maximize their UCVA. IOL selection in this situation is challenging because these individuals are typically active members of the workforce who require crisp intermediate and near visual acuity. My colleagues and I therefore conducted a study to evaluate patient satisfaction when vitrectomy was combined with the implantation of an extended depth of focus (EDOF) IOL (AT LARA, Carl Zeiss Meditec).1 WHY AN EDOF IOL? Traditional multifocal IOLs are designed to provide better near visual acuity and greater spectacle independence than monofocal IOLs.2 Patients who receive multifocal IOLs, however, are more likely to experience glare, halos,2,3 and reduced contrast sensitivity.3 An EDOF lens was selected for our study because it can provide good intermediate visual acuity with fewer unwanted visual effects.4 Participants with more than mild corneal astigmatism received a toric model. Earlier research demonstrated high patient satisfaction with EDOF lenses.5,6 Our study is the first to gauge patient satisfaction with an EDOF IOL implanted following a vitrectomy. The study also explored whether unilateral or bilateral IOL status had an impact on quality of life. METHODOLOGY Patients who underwent a vitrectomy at the University Hospitals Leuven in Belgium from January 2019 to January 2022 were invited to participate in our study. In addition to patients with vision-threatening conditions such as retinal detachment (RD) and epiretinal membrane, the study enrolled a small number of individuals who elected to undergo a vitrectomy to remove floaters. Among patients with an RD, only those with macula-on detachments at the time of the procedure or those with macula-off detachment of less than 24 hours’ duration were included.

Optimizing the Business of Dry Eye

Practical guidance for success.

Patti Barkey, COE

Cataract and Refractive Surgery Today

Management of Advanced Glaucoma

Nathan M. Radcliffe, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD

Eyetube

The Development and Impact of the Malyugin Ring

The journey of a groundbreaking device in cataract surgery that revolutionized pupillary dilation techniques.

Boris Malyugin, MD, PhD

Cataract and Refractive Surgery Today

Dry Eye Diagnostics for Beginners

It is possible to start simply and expand offerings later.

Kenneth Beckman, MD, FACS

Cataract and Refractive Surgery Today

Effective Preoperative Assessment and Management of the Ocular Surface

Tips for optimizing the ocular surface and therefore surgical success.

Priya M. Mathews, MD, MPH

Cataract and Refractive Surgery Today

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Eyewire News

Stay Updated

Retina

Adopting Remote Monitoring and AI: Lessons From Cardiology

Learning from colleagues in other medical specialties can guide ophthalmology’s smooth transition.

Judy E. Kim, MD, FARVO, FASRS, and Jagmeet P. Singh, MD, ScM, PhD, FHRS, FACC

Retina Today

AT A GLANCE The use of remote monitoring and AI is inevitable in the field of retina. However, concerns related to workflow, liability, and reimbursement hinder its adoption in day-to-day practice. Cardiology has found remote monitoring and AI to be fundamental to modern practice, benefitting both patients and providers. By learning about cardiology’s experience with adopting remote monitoring and AI in clinical practice, ophthalmologists can anticipate (and adjust for) the new era in medicine. The more ophthalmology embraces remote monitoring, the better it can meet the needs of patients and reduce treatment burden. As regulatory bodies move closer to approving home-based imaging platforms, such as home OCT and AI-based software, ophthalmologists must prepare for more data-driven care. To learn more about what this transition entails, ophthalmology can turn to other specialties with experience in widespread adoption of AI and remote monitoring. Although we practice in separate domains of medicine—retina (Dr. Kim) and cardiology (Dr. Singh)—we share a passion for improving patient care through technology.

Research Considerations During Retina Fellowship

Two fellows offer their pearls to help others start their research journey.

Olufemi Adams, MD

Retina Today

Successful Management of Vitreous Opacities

Eyetube

Tailoring IVT Dosing With Vitreous Volume

We have heard the adage, “As much as necessary, as little as possible,” with regard to medication. Can we apply it to intravitreal therapy?

Andreas F. Borkenstein, MD

Retina Today

New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery

Lediana Goduni, MD, Matt Starr, MD, and Joshua Uhr, MD

Eyetube

Capturing Geographic Atrophy with Multimodal Imaging

Noninvasive technologies are redefining how we diagnose and monitor atrophic AMD.

Eric H. Souied, MD; Oudy Semoun, MD; and Vittorio Capuano, MD

Retina Today

04.23.2024

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

Eyewire News

04.20.2024

Retina Community Mourns the Loss of Ramin Tadayoni, MD, PhD

Eyewire News

04.19.2024

Ocugen Completes Dosing in Phase 1/2 Trial of OCU410 for Geographic Atrophy

Eyewire News

04.18.2024

Ocular Therapeutix Releases Topline Results for Phase 1 Trial of Axpaxli for Diabetic Retinopathy

Eyewire News

Glaucoma

Is Glaucoma Policy Short-Sighted?

Redefining innovation to keep an eye on patient access.

Sara Riaz, MSc; Blake Oberfeld, MD; Hani El Helwe, MD; Henisk Falah, BS; and David Solá-Del Valle, MD

Glaucoma Today

Glaucoma is an incurable disease and a leading cause of blindness that is expected to affect up to 120 million people by 2040.1 In the United States, glaucoma specialists complete at least 13 years of rigorous training to manage this prevalent disease, yet reimbursement for glaucoma care is largely dictated by US health insurance payers. Last year, multiple Medicare Administrative Contractors (MACs) announced that they would no longer cover several MIGS procedures. Ultimately, lobbying by patient advocacy groups, glaucoma specialists, and ophthalmology societies, among others, led to the reversal of this controversial coverage policy.2 Nevertheless, other modern and effective glaucoma treatments such as certain standalone and combined MIGS procedures, drug delivery systems, new antiglaucoma medications, and preservative-free antiglaucoma drugs remain at risk of coverage restrictions. When insurers do not cover costs, patients must either pay out of pocket or lose access, potentially worsening inequities in eye care.3 Health care policy plays a crucial role in controlling the costs of care at a population level. However, policies guiding glaucoma care should also account for the lack of curative therapies, the limitations of feasible research, patient-specific factors directing treatment, and the burden of patient nonadherence. In this sense, we would argue that, for glaucoma policy, reimbursement rules should not be designed to discourage research and innovation and that, for ophthalmologists, innovation should not stop at the development of new drugs and devices. To balance care and costs, innovation should continue through the long-term study of cost-effectiveness and quality-of-life improvements that existing glaucoma drugs and devices can offer. With the help of industry and government, ophthalmologists should be ready to lead data-driven policy reform, ensuring that patients can access the care they need and deserve. AT A GLANCE Glaucoma policy determinations may be failing to meet the goals of patients and practitioners as well as the overall policy goal of controlling costs. The ophthalmology community and policymakers must take innovation a step further by studying the long-term cost-effectiveness of existing treatments and the impact that restrictive coverage policies can have on patient quality of life.

Screening and Establishing a Diagnosis With OCT

Closer consideration of nonglaucomatous conditions is warranted.

Sanjay Asrani, MD

Glaucoma Today

The Buzz on Eyetube

Glaucoma Today

Triple Threat: Combination OMNI and Hyrdus

Roman Krivochenitser, MD

Eyetube

The Glaucoma Tension

Arsham Sheybani, MD

Glaucoma Today

Sulcus Placement of Glaucoma Drainage Device

Ahmed Samir, MD

Eyetube

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

Featured Podcasts

Ophthalmology off the Grid

Open. Outspoken. It's Ophthalmology off the Grid—an honest look at controversial topics in the field.

View Feed

New Retina Radio

New Retina Radio is a place to hear stories about retina that are told nowhere else.

View Feed

Pupil Pod

A case-based podcast hosted by Sila Bal, MD, MPH, featuring all stages of the journey through ophthalmology, from first-year residents to the leading experts.

View Feed

Optometry

Managing Keratoconus With Scleral Lenses

Advances in technology have driven significant improvements in patient care and outcomes.

Jason E. Compton, OD, FAAO

Modern Optometry

Scleral lenses have become a cornerstone in the management of keratoconus. They now offer a new approach to a condition that has been traditionally challenging to correct with other optical solutions. These lenses, characterized by their large diameter that vaults over the cornea and rests on the sclera to create a smooth optical surface that effectively mitigates corneal irregularities, have experienced significant evolution in both design and application to enhance the visual acuity of patients with keratoconus.1 Studies have demonstrated that scleral lenses provide patients a markedly improved mean logMAR visual acuity compared with traditional glasses and rigid gas permeable lenses.2 This advancement has not only broadened the scope of visual rehabilitation for patients with keratoconus, but has also paved the way for more practitioners to get involved in their care. ADVANCES IN SCLERAL LENS TECHNOLOGY Over the past decade, scleral lens technology has undergone transformative improvements in design, material, manufacturing technology, and fit, which has significantly affected the treatment of keratoconus. These advances are not just incremental; they represent a paradigm shift in how scleral lenses are used to enhance patient outcomes. Design Recent innovations in scleral lens design have been driven by a deeper understanding of the optical and physiological challenges of managing keratoconus. For instance, the introduction of customizable front-surface eccentricity and toricity directly addresses the unique higher-order aberrations seen in keratoconus.3,4 Other design advances involve better alignment with the ocular shape, including sector-specific and purely custom zones. Practitioners can now accommodate the most extreme variations in landing zones, improving comfort and stability without compromising corneal integrity.5 Material The evolution of scleral lens materials from PMMA to silicone hydrogel represents a leap forward for corneal health. Hyper Dk materials mark another significant advance, offering unparalleled oxygen permeability to promote corneal health in our patients with keratoconus, reduce the risk of corneal edema, and support extended wear times without compromising comfort or vision.6,7 Manufacturing The adoption of computer-assisted design and manufacturing technologies has ushered in a new era of precision in scleral lens production. These technologies allow the fabrication of lenses that are custom-molded to the wearer’s unique ocular surface topography, offering an unprecedented level of fit customization.

Autoimmune Disease and the Eye

Many affected patients will present with ocular signs and symptoms.

Anthony DeWilde, OD, FAAO

Modern Optometry

The Promise of Drug-Eluting Contact Lenses

The future looks bright for this technology.

Alex Hynes, OD, FAAO

Modern Optometry

The State of Optometry’s Financial Health

Five takeaways from the largest income survey conducted in optometry.

Aaron Neufeld, OD

Modern Optometry

A Place for House Calls in Optometry

Consider delivering eye care where it’s needed most.

Damaris Raymondi, OD, FAAO

Modern Optometry

Realize the Power of Comanagement

Build community with your local providers to ensure your patients receive the best possible care.

Jeff Banas, OD

Modern Optometry

04.23.2024

DigitalOptometrics Surpasses 2 Million Remote Eye Exams

Eyewire News

04.10.2024

Orbis Partners and Heidelberg Engineering Partner to Train Eye Care Professionals Around the World

Eyewire News

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Eyewire News

04.05.2024

Wearing Glasses Boosts Income by a Third in Low-Income Communities, Finds Landmark New Study

Eyewire News

Business

Achieving Staffing Excellence

Master this cornerstone of practice success by defining each staff member’s specific role.

Jason E. Compton, OD, FAAO

Modern Optometry

In the realm of optometry, where the importance of technical expertise and advanced equipment is often highlighted, one could argue that the true marker of a successful practice is, undoubtedly, its staff. Each team member, from the doctors to the lab technicians, plays a pivotal role in ensuring that the practice operates like a well-oiled machine. Their collective skills, dedication, and interaction with patients form the foundation of a thriving practice. Understanding and optimizing each staff member’s unique role is not only beneficial, but it is also essential for delivering exceptional eye care and sustaining business growth. This article reviews the specific contributions of each staff role in an optometry office and offers tools to enhance your team’s effectiveness and growth. DOCTORS: THE VISIONARIES OF EYE CARE In an optometry practice, doctors are not simply health care providers; they are often the driving force behind the business. Whether they are practice owners or employees in a multi-doctor practice, their role transcends clinical duties. Particularly for those doctors who also manage the practice, they embody the vision and values of the business, playing a key role in its strategic direction and growth. Their ability to balance patient care with business credentials is critical in shaping practice success. Although continuing education is a requirement for licensure, doctors can adopt a more strategic approach to meeting this obligation.

How to Implement the –JZ Modifier

Reporting zero waste when administering therapeutics is going to look a little different this year. Here’s why.

Joy Woodke, COE, OCS, OCSR

Retina Today

Determining When to Use Modifiers -58 and -78

Both are used in association with the original surgery, but ultimately serve different purposes.

Joy Woodke, COE, OCS, OCSR

Retina Today

Five Retina Coding Updates for 2024

Enter the new year with a better understanding of what to expect in your billing department.

Joy Woodke, COE, OCS, OCSR

Retina Today

Healthy Habits for Glaucoma Patients

Moderation and communication are key.

Valentina Lozano, MD

Glaucoma Today

5 Steps to Building Financial Security

Planning for the future can feel overwhelming. Here’s how to make it simpler.

Christopher Lopez, OD

Modern Optometry

04.16.2024

Regeneron Backs $500 Million Venture Capital Fund for Biotechnology Innovation

Eyewire News

04.16.2024

EyeSouth Partners Affiliates With Community Eye Care Specialists in New York

Eyewire News

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

Eyewire News

04.12.2024

False Claims Act Complaint Filed Against Regeneron for Fraudulent Drug Pricing Reporting

Eyewire News

Eyewire News

04.20.2024

Retina Community Mourns the Loss of Ramin Tadayoni, MD, PhD

04.23.2024

DigitalOptometrics Surpasses 2 Million Remote Eye Exams

04.23.2024

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

04.22.2024

Alivi Health Unveils New Vision Program

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

EyewireTV

04.17.2024

The Latest EyewireTV

Executive Updates

Bausch + Lomb

Alcon

Stocks

Cataract

The Metaverse in Ophthalmology?

Chandelier Retroillumination in a Complex Cataract Extraction

Combining Vitreoretinal Surgery With EDOF IOL Implantation

Artificial Intelligence Assisted Eye Care

Dense Cataract in Pseudoexfoliation Syndrome

Effective Preoperative Assessment and Management of the Ocular Surface

04.19.2024

BVI’s Podeye Hydrophobic Monofocal IOL Launched in Japan

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.12.2024

Robotic Cataract Surgery Using ForSight Robotics’ Oryom Platform Presented for the First Time at ASCRS

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

Refractive

Combining Vitreoretinal Surgery With EDOF IOL Implantation

Optimizing the Business of Dry Eye

Management of Advanced Glaucoma

The Development and Impact of the Malyugin Ring

Dry Eye Diagnostics for Beginners

Effective Preoperative Assessment and Management of the Ocular Surface

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

First Patient Enrolled in LYNX-2 Phase 3 Study Evaluating Phentolamine for the Treatment of Decreased VA Under Low Light Conditions Following Keratorefractive Surgery

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug

04.04.2024

Zeiss Completes Acquisition of Dutch Ophthalmic Research Center (DORC)

Stay Updated

Follow Eyewire News

Retina

Adopting Remote Monitoring and AI: Lessons From Cardiology

Research Considerations During Retina Fellowship

Successful Management of Vitreous Opacities

Tailoring IVT Dosing With Vitreous Volume

New Retina Radio Journal Club with VBS: Visual Outcomes Following Surgical RRD Repair Relative to Foveal Status and Time of Surgery

Capturing Geographic Atrophy with Multimodal Imaging

04.23.2024

New Ocular Telehealth Program Enables Diabetic Retinopathy Screening

04.20.2024

Retina Community Mourns the Loss of Ramin Tadayoni, MD, PhD

04.19.2024

Ocugen Completes Dosing in Phase 1/2 Trial of OCU410 for Geographic Atrophy

04.18.2024

Ocular Therapeutix Releases Topline Results for Phase 1 Trial of Axpaxli for Diabetic Retinopathy

Glaucoma

Is Glaucoma Policy Short-Sighted?

Screening and Establishing a Diagnosis With OCT

The Buzz on Eyetube

Triple Threat: Combination OMNI and Hyrdus

The Glaucoma Tension

Sulcus Placement of Glaucoma Drainage Device

04.15.2024

iHealthScreen Awarded US Patent on Glaucoma Detection Based on AI and Color Fundus Imaging

04.15.2024

Ocular Therapeutix Names Pravin U. Dugel, MD, President and CEO

04.11.2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating Aqueous Outflow Restorative Procedure with OMNI

04.09.2024

Oasis Medical Introduces SOFT PLUG Extended Duration 180-T Tapered Plug